1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Therapy

What Are the Most Profitable Therapies? Market Trends & Strategies Explained

  • Currently 2/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
9 votes

Topics under Therapy

Global Therapy Industry 

The global therapy industry (one large revenue center of the pharma industry) involves treatments intended to protect from, cure or manage specific illnesses. The treatment of each therapeutic area and its specific conditions varies widely.

Therapy is usually decided on once the patient has been diagnosed with a specific medical condition or disease, though therapies may also be preventive measures. Therapies applied following diagnosis are either abortive or supportive. The former is a curative measure that seeks to inhibit development of the condition, while the latter relieves the patient’s suffering due to the symptoms of the disease without treating the condition itself.

Preventive therapies are used to safeguard people against disease; for example, vaccinations are used to prevent infections such as polio, smallpox and measles.

Market Trends

The combined market for medicines and therapies (such as oncology) used in the treatment of disease is witnessing a slower rate of spending: in the five years up to 2010, spending on medicines grew by more than 6% yearly. However, in the five years up to 2015, the rate of growth is slowing to between 3% and 6%. Global spending on medicine and therapy in 2015 is forecast to reach $1.1 trillion, reports the IMS Institute for Healthcare and Informatics.

The market is to see increased spending on generic drugs, hitting almost 40% growth in 2015 or nearly doubling in a decade. Spending on brand-name medicines should drop by $120 billion in the five-year period ending in 2015.

Increased prevalence of type 2 diabetes, particularly in emerging markets such as China, Brazil and India, will see global spending on the disease rise 4%-7% through 2015, with oral antidiabetics increasingly favored. Spending on therapeutic medicine to treat asthma and chronic obstructive lung disease will drop from 9% in the five-year period ending in 2010 to 2%-5% from 2010 to 2015.

Therapy Spending Forecasts to 2015 *In US$ Billion 

Key Market Segments

According to a report by the IMS Institute for Healthcare Informatics, oncology will continue to hold the top spot in the therapies industry, with forecast revenue between $75 billion and $80 billion in 2015, representing a jump of more than $20 billion in a five-year period. Lipid regulators will fall from second to fourth place, reaching between $29 billion and $34 billion in the same period. Meanwhile, anti-diabetics will rise to second place at between $43 billion and $48 billion.

Respiratory agents are expected to remain the third-biggest seller, with a $5 billion to $10 billion increase on 2010 sales. Drugs to treat hypertension are forecast to rise to fifth place with an up to $6.5 billion increase in revenue. Overall, auto-immune drugs should see a substantial jump to reach between $27 billion and $32 billion by 2015.

HIV antivirals are expected to jump from tenth to seventh place with sales of between $20 billion and $24 billion by 2015. A substantial drop in market share is expected for antidepressants, from more than $20 billion in 2010 to between $13 billion and $16 billion in 2015.  Treatments for multiple sclerosis should rise several places in the same period, marking revenue from under $10 billion to between $12 billion and $15 billion. Antipsychotics are forecast to see a $5 billion drop to $20 billion in 2015.

Therapy segments expected to drop out of the top-20 list include vitamins and minerals, antirheumatics, cephalosporins, combs (antibiotics) and vaccines. Categories expected to appear in the top 20 include treatments for glaucoma, Alzheimer’s, osteoporosis and attention deficit hyperactivity disorder.

Categories expected to show less substantial fluctuation include narcotic analgesics, antiepileptics and erythropoietics.

Top 20 Global Therapeutic Categories (2015) 

Read more ยป

Share
24/7 Customer Support

Talk to Sam

+1 646 893 5945

1-10 of about 29000 reports

Global Therapy Market and Chemotherapy Market

  • August 2017
    13 pages
  • Therapy  

    Chemotherapy  

  • World  

    United Kingdom  

View report >

Therapy and Hormone Market in the US

  • October 2017
    16 pages
  • Therapy  

    Hormone  

    Cancer Hormonal...  

  • United States  

View report >

Therapy Market in Europe

  • October 2017
    11 pages
  • Diabetes  

  • Europe  

View report >

Therapy Market and Targeted Therapy Market in the US and Asia

  • June 2017
    9 pages
  • Therapy  

    Targeted Therap...  

    Chemotherapy  

  • United States  

View report >

Therapy Market in Japan

  • October 2017
    5 pages
  • Targeted Therap...  

  • Japan  

View report >

Therapy Market in France

  • April 2017
    5 pages
  • Therapy  

  • France  

View report >

Therapy Market in Germany

  • September 2017
    14 pages
  • Therapy  

  • Germany  

View report >

Therapy Market and Cardiovascular Disease Statistics in Chad and Italy

  • September 2017
    8 pages
  • Therapy  

    Cardiovascular ...  

    Stroke  

  • Chad  

    Italy  

View report >

Therapy Market in the UK

  • October 2017
    9 pages
  • Therapy  

  • United Kingdom  

View report >

Antidiabetics and Therapy Market in Canada and the US

  • September 2017
    105 pages
  • Antidiabetics  

    Biguanide  

    Therapy  

  • Canada  

    United States  

View report >


About 10000 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 220 - $ 75000)

Immunodiagnostics Analyzers and Reagents Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • July 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

Clinical Chemistry Reagents And Analyzers Market 2021: ...

May 2017 $ 75000

2017 World Clinical Chemistry Market: North America, Eu ...

January 2017 $ 75000

Tumor Markers Testing Market 2021: A 74-country Analysi ...

June 2017 $ 52400

Cancer Diagnostics Market 2021: A 74-country Analysis-- ...

May 2017 $ 52400

2017 World Tumor Marker Diagnostics Market: North Ameri ...

January 2017 $ 52400

2017 World Cancer Diagnostics Market: North America, Eu ...

January 2017 $ 52400

2016 Tumor Markers In 32 Countries: Supplier Shares And ...

October 2016 $ 47400

Europe Immunodiagnostics Analyzers And Reagents Market ...

July 2017 $ 37500

Europe Clinical Chemistry Reagents And Analyzers Market ...

May 2017 $ 37500

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.